Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIA

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 900 participants.

Also called NCT06196047

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 900 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06196047
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Egypt (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06196047. Randomized; double masking; primary purpose treatment. Start 2023-12-01 (actual); primary completion 2024-12-20 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIA
Intervention (Drug)
Ticagrelor 90 MG
Intervention (Drug)
Cilostazol 100 MG
Lead sponsor
Kafrelsheikh University (class: other)

Record details

Record id
cardio:ct-nct06196047
Content hash
a404ba6a3cb7cc0a1fc4c1c7d4433cb9b0cb47b182463b5782f5f57874483206